The Etiology and Diagnosis of Status Epilepticus

Epilepsy and Behavior

Volumn 2, Issue 4, 2001, Pages 311-317

  Tatum IV, W O ^a,e   French, J A ^c   Benbadis, S R ^a,b   Kaplan, P W ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NONE   (United States)

Author keywords

Brain; Causes; Convulsive; Emergency; Injury; Nonconvulsive; Outcome; Seizures; Status epilepticus; Treatment

Indexed keywords

EID: 0041593430     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2001.0195     Document Type: Review

References (70)

1. Wilson JV, Reynolds EH. Translation and analysis of cuneiform text forming part of a Babylonian treatise on epilepsy. Med Hist 1990;34:185-98.
2. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995;12:316-25.
3. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-35.
4. Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia 1999;40(suppl 1):S3-8.
5. Proposal for revised clinical and electroencephalographic classification of epileptic seizures: from the Commission on Classification and Terminology of the International League against Epilepsy. Epilepsia 1981;22:489-501.
6. Gastaut H. Classification of status epilepticus. Adv Neurol 1983;34:15-35.
7. Dodson WE, DeLorenzo RJ, Pedley TA, Shinnar S, Treiman DM, Wannamaker BB. The treatment of convulsive status epilepticus: recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993; 270:854-9.
8. Bleck TP. Management approaches to prolonged seizures and status epilepticus. Epilepsia 1999;40(suppl 1):S59-63.
9. Treiman DM, DeGiorgio CM, Salisbury SM, Wickboldt CL. Subtle generalized convulsive status epilepticus. Epilepsia 1984;25:653.
10. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990;5:49-60.
11. Kaplan PW. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 1999;16:341-52.
12. Kaplan PW. Nonconvulsive status epilepticus in the emergency room. Epilepsia 1996;37:643-50.
13. Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000;54:340-5.
14. Krumholz A. Epidemiology and evidence for morbidity of nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16: 314-22.
15. Jordan KG. Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol 1999;16:332-40.
16. Drislane FW. Evidence against permanent neurologic damage from nonconvulsive status epilepticus. J Clin Neurophysiol 1999;16:323-31.
17. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998;39:833-40.
18. Tatum IV WO, Genton P, Bureau M, Dravet C, Roger J. Infrequent Epilepsy Syndromes. In: Wyllie E, editor. The treatment of epilepsy: practice and principles. 3rd ed. Baltimore: Williams & Williams, 2001:551-575.
19. Galanopoulou AS, Bojko A, Lado F, Moshe SL. The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep. Brain Dev 2000;22:279-95.
20. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 1990;40(suppl 2):9-12.
21. Fountain NB. Status epilepticus: risk factors and complications. Epilepsia 2000;41(suppl 2):S23-30.
22. Shinnar S, Pellock JM, Moshe SL, et al. In whom does status epilepticus occur: age-related differences in children. Epilepsia 1997;38:907-14.
23. Shinnar S, Maytal J, Krasnoff L, Moshe SL. Recurrent status epilepticus in children. Ann Neurol 1992;31:598-604.
24. Teitelbaum JS, Zatorre RJ, Carpenter S, et al. Neurologic sequellae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med 1990;322:1781-7.
25. Kapur J. Hippocampal neurons express GABA A receptor insensitivity to diazepam in hyperexcitable conditions. Epilepsia 2000;41(suppl 6):S86-9.
26. Treiman DM. Generalized convulsive status epilepticus in the adult. Epilepsia 1993;34(suppl 1):S2-11.
27. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995;12:326-42.
28. Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med 1980;69:657-66.
29. Blennow G, Brierley JB, Meldrum BS, Siesjo BK. Epileptic brain damage: the role of systemic factors that modify cerebral energy metabolism. Brain 1978;101:687-700.
30. Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates: ischemic cell change and its relation to ictal physiological events. Arch Neurol 1973;28:10-17.
31. Fujikawa DG, Itabashi HH, Wu A, Shinmei SS. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 2000;41:981-91.
32. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med 1998;338:970-6.
33. Wasterlain CG, Fujikawa DG, Penix L, Sankar R. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 1993;34(suppl 1):S37-53.
34. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-34.
35. Maytal J, Shinnar S, Moshe SL, et al. Low morbidity and mortality of status epilepticus in children. Pediatrics 1989;93: 323-31.
36. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
37. Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic and toxic-metabolic encephalopathies. Arch Neurol 1988;45:781-4.
38. Dodrill CB, Wilensky AJ. Intellectual impairment as an outcome of status epilepticus. Neurology 1990;40(suppl 2):23-7.
39. Shorvon S. In: Status epilepticus: its clinical features and treatment in chidren and adults. Complex partial status epilepticus. Cambridge, UK: Cambridge Univ. Press, 1994:116.
40. Kaplan PW. Prognosis in nonconvulsive status epilepticus. Epileptic Disord 2000;2:185-93.
41. Krumholz A, Sung GY, Fisher RS, et al. Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology 1995;45:1449-504.
42. DeLorenzo RJ, Garnett LK, Towne AR, et al. Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29 minutes. Epilepsia 1999;40:164-9.
43. Kaplan PW. Functional outcome following nonconvulsive status epilepticus. Epilepsia 1997;38(suppl 8):224.
44. Litt B, Wityk RJ, Hertz SH, et al. Nonconvulsive status epilepticus in the critically ill elderly. Epilepsia 1998;39:1194-202.
45. Christensen RC, Szlabowicz JW. Factitious status epilepticus as a particular form of Munchausen's syndrome. Neurology 1991; 41:2009-10.
46. Privitera MD, Strawsburg RH. Electroencephalographic monitoring in the emergency department. Emerg Med Clin North Am 1994;12:1089-100.
47. Tatum WO, Ross J, Cole AJ. Epileptic pseudodementia. Neurology 1998;50:1472-5.
48. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol 1995;12:343-62.
49. Drislane FW, Blum AS, Schomer DL. Focal status epilepticus: clinical features and significance of different EEG patterns. Epilepsia 1999;40:1254-60.
50. Tatum WO, Alavi A, Stecker MM. The utility of Tc-HMPAO SPECT in partial status epilepticus. J Nucl Med 1994;35:1087-94.
51. Tatum WO, Sperling MR, Jacobstein JG. Epileptic palatal myoclonus. Neurology 1991;41:1305-6.
52. Thomas P, Zifkin B, Migneco O, Lebrun C, Darcourt J, Andermann F. Nonconvulsive status epilepticus of frontal origin. Neurology 1999;52:1174-83.
53. Benbadis SR, Tatum WO IV. Prevalence of nonconvulsive status epilepticus in comatose patients [letter]. Neurology 2000; 55:1421-3.
54. Lee SI. Nonconvulsive status epilepticus: ictal confusion in later life. Arch Neurol 1985;42:778-81.
55. Kaplan PW. Benzodiazepine-responsive confusion: is this NCSE? In: American Clinical Neurophysiology Society Meeting. Montreal, Canada, September 2000.
56. Towne AR, DeLorenzo RJ. Use of intramuscular midazolam for status epilepticus. J Emerg Med 1999;17:323-8.
57. DeToledo JC, Ramsay RE. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased cost. Drug Saf 2000;22:459-66.
58. Cereghino JJ, Mitchell WG, Murphy J, Kriel RL, Rosenfeld WE, Trevathan E, and The North American Diastat Study Group. Treating repetitive seizures with a rectal diazepam formulation: a randomized study. Neurology 1998;51:1274-82.
59. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998;339:792-8.
60. Kaplan PW. Intravenous valproate treatment of generalized nonconvulsive status epilepticus. Clin Electroencephalogr 1999;30:1-4.
61. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with SE. Neurology 2000;55:722-4.
62. Holmes GL, Riviello JJ Jr., Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999;20:259-64.
63. Labar DR, Ali A, Root J. High-dose intravenous lorazepam for the treatment of refractory status epilepticus. Neurology 1994; 44:1400-3.
64. Hanley DF, Pozo M. Treatment of status epilepticus with midazolam in the critical care setting. Int J Clin Pract 2000;54: 30-5.
65. Brown LA, Levin GM. The role of propofol in refractory status epilepticus. Ann Pharmacother 1998;32:1053-9.
66. Stecker MM, Kramer TH, Raps EC, O'Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 1998;39:18-26.
67. Uberall MA, Trollmann R, Wunsiedler U, Wenzel D. Intravenous valproate in pediatric epilepsy patients with refractory status epilepticus. Neurology 2000;54:2188-9.
68. Osorio I, Reed RC, Peltzer JN. Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia 2000;41:887-94.
69. Sheth RD, Gidal BE. Intravenous valproic acid for myoclonic status epilepticus. Neurology 2000;54:1201.
70. Fujikawa DG. Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 1995;36:186-95.